Replies to post #39174 on Amarantus Bioscience Holdings Inc (AMBS)

[Disney714]

FDA approval soon?

A consensus meeting with the FDA to obtain agreement with the clinical plan and submission data package is planned this year to insure timely regulatory agency review and positive marketing approval

The MANF biomarker may identify the right people to treat at the earliest stage of the development of diabetes. Generex Oral-lyn™ may be the best way to deliver the small amounts of insulin needed to block the immunologic destruction of the beta cells in otherwise healthy children and young adults without causing hypoglycemia.

http://investor.generex.com/releasedetail.cfm?releaseid=585490